VNVALUEVNVALUE
Updated weekly
Back to Dashboard
Consumer sector

BCP

Consumer
Công ty Cổ phần Dược Enlie
Y tế/Dược phẩmCT
9.600
VND · Last close
Valuation Verdict
Overvalued
Very Low
-120%Fair Value+120%
Intrinsic Value
3.119
Current
9.600
Gap
-67.5%
ModelFCF DCF

Valuation Breakdown

CTY tếConsumer
Classified as consumer because ICB sector "Y tế" maps to the consumer group
ModelFCF-Based DCF
Value = Sum of [FCF / (1+WACC)^t] + Terminal Value / (1+WACC)^n

A classic Discounted Cash Flow model built on Free Cash Flow (FCF), the actual cash a business generates after all operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted back to today's value using WACC. This is the gold standard of intrinsic valuation: it values the company based on what it can actually deliver to shareholders, independent of market sentiment.

Distressed Valuation
Negative Intrinsic Value
BVPS
6.239
x
Discount
50%
=
Floor Value
6.239

Valuation Track Record

Retroactive intrinsic value vs actual close price — BCP

Earnings Quality

Fiscal year 2025

42
Weak
Accrual Quality
85
Cash Conversion
0
Receivables
76
Margin Stability
0
Revenue Quality
36

Financial Forensics

Beneish M-Score · 2025

-2.04
Moderate
DSRI
1.239
GMI
0.974
AQI
0.723
SGI
1.219
DEPI
0.917
SGAI
0.969
TATA
0.037
LVGI
1.065

BCP shows signs of potential earnings manipulation with a Beneish M-Score of -2.044, indicating a risk of financial misrepresentation. The earnings quality score of 41.8/100, particularly low cash conversion and revenue metrics, further highlights concerns about the sustainability of reported earnings.

Red Flags
  • Beneish M-Score of -2.044 is below the manipulation threshold of -1.78, suggesting potential earnings manipulation.
  • Earnings Quality Score of 41.8/100, with cash conversion at 0.0/100, indicates severe issues in converting earnings into cash.
Positive Signals
  • DSRI of 1.2386 indicates that inventory growth is in line with revenue growth, which may suggest some operational stability.
  • The GMI of 0.9744 suggests that gross margin is stable, which is a positive indicator in terms of cost management.
Ownership Risk

The high concentration of ownership, with Công ty Cổ Phần Dược Đại Nam holding 67.3%, raises concerns about minority shareholder rights and potential conflicts of interest in decision-making.

Recommendation

Investors should proceed with caution, closely monitoring future earnings reports and cash flow statements. Consider reducing exposure or implementing stricter due diligence before making investment decisions.

Generated by AI based on quantitative data. Not financial advice.

Quantitative Scores

F-Score
4/9
Neutral
Z-Score
1.53
Distress Zone
Sharpe
0.16
Positive
Composite
34
Weak
Price Risk
Momentum
+7.5%
Volatility
103.9%
Max Drawdown
-30.8%

Key Ratios

Fiscal year 2025
22.08P/E
P/B1.54
P/S0.32
ROE7.2%
ROA2.1%
EPS434.78
BVPS6238.89
Gross Margin10.9%
Net Margin1.5%
D/E2.72
Current Ratio1.01
Rev Growth21.9%
Profit Growth656.3%
EV/EBITDA9.30
Div Yield0.0%

Company Overview

Issued Shares
6.0M
Charter Capital
60.0B VND
Sector (ICB L2)
Y tế
Industry (ICB L3)
Dược phẩm
Sub-industry
Dược phẩm
Company Type
CT

// OWNERSHIP_NETWORK

> mapping common ownership for BCP — hover nodes for intel, click to navigate

Shareholders
Công ty Cổ Phần Dược Đại Nam
Inst
67.3%
4.0 trieu
An Mạnh Hùng
Indiv
4.2%
253.100
Phan Thanh Long
Indiv
4.1%
245.000
Công ty Cổ phần Dược Hậu Giang
Inst
2.9%
175.000
Phan Thanh Phương
Indiv
1.7%
100.000
Phạm Thanh Long
Indiv
0.8%
45.100
nguyen-thanh-trung
Indiv
0.4%
18.000
Đặng Thị Như Huyền
Indiv
0.3%
20.000
Giang Quốc Dũng
Indiv
0.2%
10.000
Board & Management
An Mạnh Hùng4.2%
Tổng Giám đốc
Phạm Thanh Long0.8%
Chủ tịch Hội đồng Quản trị
Lê Minh Trí
Thành viên Hội đồng Quản trị
Phan Thanh Sơn
Thành viên Hội đồng Quản trị
Nguyễn Thành An
Thành viên Ban kiểm soát
Phạm Thị Liên
Trưởng Ban kiểm soát
Trương Chí Cả
Thành viên Ban kiểm soát
Phạm Văn Dũng
Thành viên Hội đồng Quản trị
Phạm Hồng Nhung
Kế toán trưởng
Lê Sỹ Tuấn
Giám đốc Sản xuất/Phụ trách Công bố thông tin
Top connections
Computed 12/04/2026
Methodology & Disclosure

vnvalue is a methodology engine — not an advisor. Every number is the deterministic output of a published formula applied to public financial data. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →